首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1555504

口腔崩解片市場，按藥物類型、適應症、配銷通路、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Orally Disintegrating Tablet Market, By Drug Type, By Indication, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年08月20日 | 出版商:

AnalystView Market Insights | 英文 390 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告要點

2023年口腔崩解片市場規模為131.2312億美元，2024年至2032年複合年成長率為8.1%。

口腔崩解片市場-市場動態

生物利用度的提高和使用便利性的提高預計將推動市場需求

ODT 可以增強某些藥物的生物利用度，使其更有效。這對於需要快速起效的藥物特別有益。 ODT 擴大用於兒科和老年護理以外的各種治療領域，包括心理健康、過敏和疼痛管理。這種更廣泛的應用有助於推動市場成長。與傳統片劑相比，患者通常更喜歡 ODT，因為 ODT 易於使用且對水的需求減少。患者依從性的提高可以帶來更好的治療結果，從而帶來更高的需求。

此外，ODT 為吞嚥傳統片劑或膠囊有困難的患者提供了實用的解決方案。這包括兒童、老年人和患有某些疾病的人。無需水即可輕鬆給藥，有助於提高患者的依從性。片劑配方技術的創新改善了 ODT 的味道、穩定性和功效。製造流程的進步使得 ODT 更加有效且對患者友善。

口腔崩解片市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.1% 左右的複合年成長率成長

根據藥物類型細分，由於過敏性疾病日益嚴重，預計抗過敏藥物細分市場將在 2023 年佔據最大市場佔有率。

根據適應症細分，由於心血管治療對 ODT 的需求很大，心血管疾病領域是 2023 年的主要適應症。

根據配銷通路細分，由於醫院對 ODT 的需求量很大，醫院藥房細分市場將成為 2023 年領先的配銷通路市場。

按地區分類，由於慢性病盛行率不斷上升，北美將成為 2023 年的主要收入來源。

口腔崩解片市場-細分分析：

全球口腔崩解片市場根據藥物類型、適應症、配銷通路和地區進行細分。

市場依藥物類型分為七類：抗精神病藥、抗癲癇藥、抗高血壓藥、抗焦慮藥、抗過敏藥、質子幫浦抑制劑等。抗過敏藥物領域佔據市場主導地位。過敏性疾病的高盛行率正在增加對抗過敏藥片的需求。

市場依適應症分為五類：神經系統疾病、心血管疾病、腸胃疾病、過敏性疾病等。心血管疾病領域佔市場主導地位。 ODT 廣泛用於治療各種心血管疾病，從而促進細分市場的成長。

根據分銷管道，市場分為三類：醫院藥房、網路藥房和其他。醫院藥房領域在市場中佔據主導地位，預計在預測期內將保持其較高的主導地位。預計線上藥局領域在預測期內將以最快的速度成長。

口腔崩解片市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。北美在全球 ODT 市場中佔有重要佔有率，這主要是由於其先進的醫療基礎設施和慢性病的高盛行率。由於醫療保健普及率不斷提高、慢性病盛行率不斷上升以及患者人數眾多，亞太地區 ODT 市場正在快速成長。印度和中國等國家的巨大市場機會是由高人口密度和不斷成長的醫療保健需求所推動的。國內藥廠開發ODT製劑的趨勢也日益明顯。

口腔崩解片市場-競爭格局：

口腔崩解片 (ODT) 市場競爭非常激烈，幾個關鍵參與者和持續的發展正在塑造其格局。市場參與者正在開發新的 ODT 配方，以改善掩味效果並縮短崩解時間。賦形劑技術和片劑基質設計的創新正在改善患者的整體體驗。主要製藥公司正致力於擴大其在亞太和拉丁美洲等新興市場的 ODT 產品供應。這種擴張是由醫療保健服務的不斷增加和對患者友善藥物的需求不斷增加所推動的。

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美口腔崩解片主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按藥物類型）
- 北美市場規模和預測（按指標）
- 北美市場規模和預測（按配銷通路）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲口腔崩解片主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模和預測（按藥物類型）
- 歐洲市場規模與預測（按指標）
- 歐洲市場規模和預測（按配銷通路）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區口腔崩解片主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模和預測（按藥物類型）
- 亞太地區市場規模與預測（依指標）
- 亞太地區市場規模和預測（按配銷通路）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲口腔崩解片主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按藥物類型）
- 拉丁美洲市場規模與預測（按指標）
- 拉丁美洲市場規模和預測（按配銷通路）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲口腔崩解片主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按藥物類型）
- 中東和非洲市場規模及預測（依指標）
- 中東和非洲市場規模及預測（按配銷通路）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 口腔崩解片產業

競爭儀表板
公司簡介
- Johnson & Johnson
- Pfizer Inc.
- Novartis AG
- Roche Holding AG
- GlaxoSmithKline (GSK)
- Viatris Inc.
- Aurobindo Pharma
- Teva Pharmaceutical Industries Ltd.
- Zydus Cadilla
- Eli Lilly and Company
- Sanofi
- Boehringer Ingelheim
- AbbVie Inc.
- Amgen Inc.
- Daiichi Sankyo
- MigVax
- Dr. Reddy's Laboratories
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV3641

REPORT HIGHLIGHT

Orally Disintegrating Tablet Market size was valued at USD 13,123.12 Million in 2023, expanding at a CAGR of 8.1% from 2024 to 2032.

An Orally Disintegrating Tablet (ODT) is a type of medication that is designed to dissolve quickly in the mouth without needing water. This can be particularly useful for people who have difficulty swallowing traditional tablets or capsules, such as children or elderly patients.

Orally Disintegrating Tablet Market- Market Dynamics

Increasing improved bioavailability and convenience to use are expected to propel market demand

ODTs can enhance the bioavailability of certain drugs, making them more effective. This is particularly beneficial for medications that require rapid onset of action. ODTs are increasingly used in a variety of therapeutic areas beyond just pediatric and geriatric care, including mental health, allergies, and pain management. This broader application helps drive market growth. Patients often prefer ODTs over traditional tablets due to their ease of use and the reduced need for water. Increased patient compliance can lead to better therapeutic outcomes and, subsequently, higher demand.

Furthermore, ODTs offer a practical solution for patients who have difficulty swallowing traditional tablets or capsules. This includes children, elderly individuals, and those with certain medical conditions. The ease of administration without needing water contributes to higher patient compliance. Innovations in tablet formulation technologies have improved the taste, stability, and efficacy of ODTs. Advances in manufacturing processes allow for more effective and patient-friendly ODTs.

Orally Disintegrating Tablet Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.1% over the forecast period (2024-2032)

Based on Drug Type segmentation, the anti-allergic drugs segment was predicted to show maximum market share in the year 2023, owing to growing allergic disorders.

Based on Indication segmentation, the cardiovascular diseases segment was the leading Indication in 2023, owing to the high need for ODTs in cardiovascular therapies.

Based on Distribution Channel segmentation, the hospital pharmacies segment was the leading Distribution Channel segment in 2023, owing to the high demand for ODTs in hospitals.

Based on region, North America was the leading revenue generator in 2023, due to the growing prevalence of chronic diseases.

Orally Disintegrating Tablet Market- Segmentation Analysis:

The Global Orally Disintegrating Tablet Market is segmented based on Drug Type, Indication, Distribution Channel, and Region.

The market is divided into seven categories based on Drug Type: anti-psychotics, anti-epileptics, anti-hypertensives, anxiolytics, anti-allergic drugs, proton pump inhibitors, and others. The anti-allergic drugs segment dominates the market. The high prevalence of allergic diseases is growing the demand for anti-allergic tablets.

The market is divided into five categories based on Indication: neurological diseases, cardiovascular diseases, gastrointestinal diseases, allergic diseases, and others. The cardiovascular diseases segment dominates the market. ODTs are widely used for treating every cardiovascular disease which boosts segment growth.

The market is divided into three categories based on Distribution Channels: hospital pharmacies, online pharmacies, and others. The hospital pharmacies segment dominates the market and is expected to maintain its high dominance during the forecast period. The online pharmacies segment is estimated to grow at the fastest rate over the forecast period.

Orally Disintegrating Tablet Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the global ODT market, largely due to its advanced healthcare infrastructure and high prevalence of chronic diseases. The Asia-Pacific region is experiencing rapid growth in the ODT market due to rising healthcare access, increasing chronic disease prevalence, and a large patient population. Significant market opportunities in countries like India and China, are driven by high population density and increasing healthcare needs. There is also a growing trend towards domestic pharmaceutical companies developing ODT formulations.

Orally Disintegrating Tablet Market- Competitive Landscape:

The Orally Disintegrating Tablet (ODT) market is highly competitive, with several key players and ongoing developments shaping its landscape. Market players are developing new ODT formulations with improved taste-masking and faster disintegration times. Innovations in excipient technologies and tablet matrix design are enhancing the overall patient experience. Major pharmaceutical companies are focusing on expanding their ODT product offerings in emerging markets such as Asia-Pacific and Latin America. This expansion is driven by growing healthcare access and increasing demand for patient-friendly medication.

Recent Developments:

In March 2023, Zydus Cadilla got FDA approval for manufacturing Olanzapine ODT for nervous system diseases.

In June 2022, Catalent and MigVax announced the utilization of Zydis Bio orally disintegrating tablet technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ORALLY DISINTEGRATING TABLET MARKET KEY PLAYERS

Johnson & Johnson
Pfizer Inc.
Novartis AG
Roche Holding AG
GlaxoSmithKline (GSK)
Viatris Inc.
Aurobindo Pharma
Teva Pharmaceutical Industries Ltd.
Zydus Cadilla
Eli Lilly and Company
Sanofi
Boehringer Ingelheim
AbbVie Inc.
Amgen Inc.
Daiichi Sankyo
MigVax
Dr Reddy's Laboratories
Others

GLOBAL ORALLY DISINTEGRATING TABLET MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019-2032

Anti-psychotics
Anti-epileptics
Anti-hypertensives
Anxiolytics
Anti-allergic Drugs
Proton Pump Inhibitors
Others

GLOBAL ORALLY DISINTEGRATING TABLET MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

Neurological Diseases
Cardiovascular Diseases
Gastrointestinal Diseases
Allergic Diseases
Others

GLOBAL ORALLY DISINTEGRATING TABLET MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019-2032

Hospital Pharmacies
Online Pharmacies
Others

GLOBAL ORALLY DISINTEGRATING TABLET MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Orally Disintegrating Tablet Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Orally Disintegrating Tablet Market Snippet by Drug Type
- 2.1.2. Orally Disintegrating Tablet Market Snippet by Indication
- 2.1.3. Orally Disintegrating Tablet Market Snippet by Distribution Channel
- 2.1.4. Orally Disintegrating Tablet Market Snippet by Country
- 2.1.5. Orally Disintegrating Tablet Market Snippet by Region
2.2. Competitive Insights

3. Orally Disintegrating Tablet Key Market Trends

3.1. Orally Disintegrating Tablet Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Orally Disintegrating Tablet Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Orally Disintegrating Tablet Market Opportunities
3.4. Orally Disintegrating Tablet Market Future Trends

4. Orally Disintegrating Tablet Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Orally Disintegrating Tablet Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Orally Disintegrating Tablet Market Landscape

6.1. Orally Disintegrating Tablet Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Orally Disintegrating Tablet Market - By Drug Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug Type, 2024 & 2032 (%)
- 7.1.2. Anti-psychotics
- 7.1.3. Anti-epileptics
- 7.1.4. Anti-hypertensives
- 7.1.5. Anxiolytics
- 7.1.6. Anti-allergic Drugs
- 7.1.7. Proton Pump Inhibitors
- 7.1.8. Others

8. Orally Disintegrating Tablet Market - By Indication

8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
- 8.1.2. Neurological Diseases
- 8.1.3. Cardiovascular Diseases
- 8.1.4. Gastrointestinal Diseases
- 8.1.5. Allergic Diseases
- 8.1.6. Others

9. Orally Disintegrating Tablet Market - By Distribution Channel

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
- 9.1.2. Hospital Pharmacies
- 9.1.3. Online Pharmacies
- 9.1.4. Others

10. Orally Disintegrating Tablet Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Orally Disintegrating Tablet Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Orally Disintegrating Tablet Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Orally Disintegrating Tablet Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Orally Disintegrating Tablet Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Orally Disintegrating Tablet Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Orally Disintegrating Tablet Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Johnson & Johnson
- 11.2.2. Pfizer Inc.
- 11.2.3. Novartis AG
- 11.2.4. Roche Holding AG
- 11.2.5. GlaxoSmithKline (GSK)
- 11.2.6. Viatris Inc.
- 11.2.7. Aurobindo Pharma
- 11.2.8. Teva Pharmaceutical Industries Ltd.
- 11.2.9. Zydus Cadilla
- 11.2.10. Eli Lilly and Company
- 11.2.11. Sanofi
- 11.2.12. Boehringer Ingelheim
- 11.2.13. AbbVie Inc.
- 11.2.14. Amgen Inc.
- 11.2.15. Daiichi Sankyo
- 11.2.16. MigVax
- 11.2.17. Dr. Reddy's Laboratories
- 11.2.18. Others